These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 28986919

  • 1. Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood.
    Schwarz C, Müller T, Lau S, Parasher K, Staab D, Wahn U.
    Pediatr Allergy Immunol; 2018 Feb; 29(1):28-33. PubMed ID: 28986919
    [Abstract] [Full Text] [Related]

  • 2. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
    Drugs R D; 2008 Feb; 9(2):125-30. PubMed ID: 18298130
    [Abstract] [Full Text] [Related]

  • 3. Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
    Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser LJ, Ring J, Griffin EF, Haig AE, Frewer PI, Parkin JM, Gleich GJ, Mepolizumab HES Study Group.
    N Engl J Med; 2008 Mar 20; 358(12):1215-28. PubMed ID: 18344568
    [Abstract] [Full Text] [Related]

  • 4. Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.
    Kuang FL, Fay MP, Ware J, Wetzler L, Holland-Thomas N, Brown T, Ortega H, Steinfeld J, Khoury P, Klion AD.
    J Allergy Clin Immunol Pract; 2018 Mar 20; 6(5):1518-1527.e5. PubMed ID: 29751154
    [Abstract] [Full Text] [Related]

  • 5. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
    Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME.
    J Allergy Clin Immunol; 2004 Jan 20; 113(1):115-9. PubMed ID: 14699394
    [Abstract] [Full Text] [Related]

  • 6. Current strategies in the management of hypereosinophilic syndrome, including mepolizumab.
    Schwartz LB, Sheikh J, Singh A.
    Curr Med Res Opin; 2010 Aug 20; 26(8):1933-46. PubMed ID: 20565230
    [Abstract] [Full Text] [Related]

  • 7. Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5.
    Mehr S, Rego S, Kakakios A, Kilham H, Kemp A.
    J Pediatr; 2009 Aug 20; 155(2):289-91. PubMed ID: 19619754
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
    Roufosse FE, Kahn JE, Gleich GJ, Schwartz LB, Singh AD, Rosenwasser LJ, Denburg JA, Ring J, Rothenberg ME, Sheikh J, Haig AE, Mallett SA, Templeton DN, Ortega HG, Klion AD.
    J Allergy Clin Immunol; 2013 Feb 20; 131(2):461-7.e1-5. PubMed ID: 23040887
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab.
    Leon-Ferre RA, Weiler CR, Halfdanarson TR.
    Clin Adv Hematol Oncol; 2013 May 20; 11(5):317-9. PubMed ID: 23880717
    [No Abstract] [Full Text] [Related]

  • 15. Hypereosinophilic syndrome and mepolizumab.
    Boucher RM, Gilbert-McClain L, Chowdhury B.
    N Engl J Med; 2008 Jun 26; 358(26):2838-9; author reply 2839-40. PubMed ID: 18579821
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypereosinophilic syndrome and mepolizumab.
    Verzegnassi F.
    N Engl J Med; 2008 Jun 26; 358(26):2838; author reply 2839-40. PubMed ID: 18584819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.